The effect of prifinium bromide (1,1-diethyl-3-(diphenylmethylene)-2-methylpyrrolidium bromide) on the gastric antral motility in man.
D000328:Adult; D001965:Bromides / Q000008:administration & dosage*; D003864:Depression, Chemical; D005471:Fluoroscopy; D005769:Gastrointestinal Motility / Q000187:drug effects*; D006801:Humans; D007273:Injections, Intramuscular; D007279:Injections, Subcutaneous; D007734:Kymography; D008297:Male; D010276:Parasympatholytics / Q000008:administration & dosage* / Q000009:adverse effects; D010919:Placebos; D011759:Pyrrolidines / Q000008:administration & dosage* / Q000009:adverse effects; D012601:Scopolamine / Q000008:administration & dosage* / Q000009:adverse effects; D013997:Time Factors
D001965:Bromides; D010276:Parasympatholytics; D010919:Placebos; D011759:Pyrrolidines; D012601:Scopolamine